Jonathan Arias

About me
Publications
CV
Public outreach and news

About me

My expertise is in the field of stem cell biology, developmental biology, gene editing, guided differentiation and regenerative medicine.

Teaching

Graduate course organizer Advanced Therapy Medicinal Products and Regenerative Medicine 2024
Vilnius University

Graduate course organizer Advanced Therapy Medicinal Products and Regenerative Medicine 2023

Vilnius University

Lecturer at Stem Cells and Gene Editing in the International Blend Intensive Program (BIP) 2024

Articles

Journal article: STEM CELL RESEARCH. 2024;:103628
Generation of a genetically encoded voltage indicator MARINA reporter human iPS cell line using Cas9 (VULSCi002-A-2)
Aistė P; Ugnė Š; Catalina MP; Barbara R; Simonas K; Beatričė V-R; Rimvydas N; Kumar VA; Patricia M; Urtė N; Artūras J; Aurelijus B; Ivan N; Jose I; Daniel N; Mindaugas S; Laimonas G; Daiva B; Jonathan A
Journal article: MOVEMENT DISORDERS. 2022;37(1):80-94
Parkinson's Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2-Hydroxypropyl-β-Cyclodextrin Treatment
Jarazo J; Barmpa K; Modamio J; Saraiva C; Sabate-Soler S; Rosety I; Griesbeck A; Skwirblies F; Zaffaroni G; Smits LM; Su J; Arias-Fuenzalida J; Walter J; Gomez-Giro G; Monzel AS; Qing X; Vitali A; Cruciani G; Boussaad I; Brunelli F; Jager C; Rakovic A; Li W; Yuan L; Berger E; Arena G; Bolognin S; Schmidt R; Schroeder C; Antony PMA; Klein C; Kruger R; Seibler P; Schwamborn JC
Article: STEM CELLS TRANSLATIONAL MEDICINE. 2021;10(7):987-995
HSC and iPS cell-derived CAR-NK cells as reliable cell-based therapy solutions
Arias J; Yu J; Varshney M; Inzunza J; Nalvarte I
Article: STEM CELL RESEARCH. 2021;51:102193
Generation of nonviral integration-free human iPS cell line KISCOi001-A from normal human fibroblasts, under defined xeno-free and feeder-free conditions
Inzunza J; Arias-Fuenzalida J; Segura-Aguilar J; Nalvarte I; Varshney M
Journal article: CELLS. 2020;9(9):2065
Using High-Content Screening to Generate Single-Cell Gene-Corrected Patient-Derived iPS Clones Reveals Excess Alpha-Synuclein with Familial Parkinson's Disease Point Mutation A30P
Barbuti P; Antony P; Santos B; Massart F; Cruciani G; Dording C; Arias J; Schwamborn J; Krueger R
Journal article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2020;112(1):55-62
The Effects of Ganglioside-Monosialic Acid in Taxane-Induced Peripheral Neurotoxicity in Patients with Breast Cancer: A Randomized Trial
Su Y; Huang J; Wang S; Unger JM; Arias-Fuenzalida J; Shi Y; Li J; Gao Y; Shi W; Wang X; Peng R; Xu F; An X; Xue C; Xia W; Hong R; Zhong Y; Lin Y; Huang H; Zhang A; Zhang L; Cai L; Zhang J; Yuan Z
Journal article: ACTA NEUROPATHOLOGICA COMMUNICATIONS. 2019;7(1):222
Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis
Gomez-Giro G; Arias-Fuenzalida J; Jarazo J; Zeuschner D; Ali M; Possemis N; Bolognin S; Halder R; Jager C; Kuper WFE; van Hasselt PM; Zaehres H; del Sol A; van der Putten H; Scholer HR; Schwamborn JC
Article: STEM CELL RESEARCH. 2019;41:101613
Generation of human induced pluripotent stem cell lines from patients with selective IgA deficiency
Arias-Fuenzalida J; Yu J; Du L; Custodio J; Notarangelo LD; Hammarstrom L; Pan-Hammarstrom Q
Article: STEM CELL RESEARCH. 2019;41:101612
Generation of a human induced pluripotent stem cell line (PHAi003) from a primary immunodeficient patient with CD70 mutation
Arias-Fuenzalida J; Yu J; Abolhassani H; Du L; Custodio J; Pan-Hammarstrom Q
Journal article: SCIENTIFIC REPORTS. 2019;9(1):9455
Automated high-throughput high-content autophagy and mitophagy analysis platform
Arias-Fuenzalida J; Jarazo J; Walter J; Gomez-Giro G; Forster JI; Krueger R; Antony PMA; Schwamborn JC
Journal article: STEM CELL REPORTS. 2019;12(5):878-889
Neural Stem Cells of Parkinson's Disease Patients Exhibit Aberrant Mitochondrial Morphology and Functionality
Walter J; Bolognin S; Antony PMA; Nickels SL; Poovathingal SK; Salamanca L; Magni S; Perfeito R; Hoel F; Qing X; Jarazo J; Arias-Fuenzalida J; Ignac T; Monzel AS; Gonzalez-Cano L; de Almeida LP; Skupin A; Tronstad KJ; Schwamborn JC
Journal article: STEM CELL REPORTS. 2017;9(5):1423-1431
FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson's Disease Modeling
Arias-Fuenzalida J; Jarazo J; Qing X; Walter J; Gomez-Giro G; Nickels SL; Zaehres H; Schoeler HR; Schwamborn JC
Journal article: STEM CELL RESEARCH. 2017;24:44-50
CRISPR/Cas9 and piggyBac-mediated footprint-free LRRK2-G2019S knock-in reveals neuronal complexity phenotypes and α-Synuclein modulation in dopaminergic neurons
Qing X; Walter J; Jarazo J; Arias-Fuenzalida J; Hillje A-L; Schwamborn JC

All other publications

Preprint: BIORXIV. 2019
Parkinson’s disease phenotypes in patient specific brain organoids are improved by HP-β-CD treatment
Jarazo J; Barmpa K; Rosety I; Smits L; Arias-Fuenzalida J; Walter J; Gomez-Giro G; Monzel A; Qing X; Cruciani G; Boussaad I; Jäger C; Rakovic A; Berger E; Bolognin S; Antony P; Klein C; Krüger R; Seibler P; Schwamborn J
Preprint: BIORXIV. 2019
Essentiality ofCREBBPinEP300truncated B-cell lymphoma revealed by genome-wide CRISPR-Cas9 screen
Nie M; Du L; Zhang B; Ren W; Joung J; Ye X; Fuenzalida JA; Shi X; Liu D; Wu K; Zhang F; Pan-Hammarström Q
Preprint: BIORXIV. 2018
Automated high-throughput high-content autophagy and mitophagy analysis platform
Arias-Fuenzalida J; Jarazo J; Walter J; Gomez-Giro G; Forster J; Antony PMA; Krueger R; Schwamborn J

About me

Teaching

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI